Cholera Treatment Market - Forecast(2024 - 2030)

Cholera Treatment Market size is forecast to reach $167.89 Million by 2025, growing at a CAGR of 8.53% during the forecast period 2020-2025. Cholera is an infectious disease that causes severe watery diarrhea, which can lead to dehydration and even death if untreated. It is caused by eating food or drinking water contaminated with a bacterium called Vibrio cholerae. Cholera requires immediate treatment as the disease can cause death within hours. Rehydration therapy, intravenous fluids, antibiotic treatment, and zinc supplements are primary treatment options for cholera. Rise in number of affected and mortality cases owing to cholera epidemic, unclean environments for pollution and lack of sanitary systems, massive awareness campaigns by government & NGOs and increase in financial investment and support for development of novel medications by key investment firms and market players are major factors that are driving the market growth in recent years. In addition, major developments by key market players like Sanofi and Novartis is also driving the growth of the market. 

The report: “Cholera Treatment Market Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Cholera Treatment Market. 

By Treatment Type: Medication, and Vaccinations

By Product Type: Suspension, and Injectable

By Route of Administration: Oral dosage, and Injectable dosage

By End Users: Hospitals, Homecare, Primary Care Provider, Specialty Clinics, and Others

By Geography: North America, Europe, Asia-Pacific, and Rest of the World

Vaccinations held the largest share in the treatment type segment of Cholera Treatment Market in 2019 and is estimated to grow at a CAGR of 9.5% during the forecast period 2020-2025. Factors that contribute to the growth of this segment are the high prevalence of cholera among the economically weaker section of the society, increasing government initiatives towards immunization, technological advancements in the vaccine industry, and a strong pipeline for vaccines. In addition, growing focus on therapeutic vaccines and emerging market players launching advanced vaccine generics aid the market growth. Medications held the second largest share in the market, owing to strategic developments by key market players, quicker relief and less regulations on manufacturing and distribution of chlorine medications. Vaccinations segment is set to be the fastest growing segment and is estimated to register the highest CAGR during the forecast period 2020-2025, owing to major investments in advancement of vaccine therapy by key market players and awareness campaigns on cholera treatment by immunization for the common people.

Hospitals dominated the market share in the end user segment of Cholera Treatment Market in 2019. Improving healthcare infrastructure in developing countries, improved financial capability of hospitals, better infection control policies and rising number of patients getting cured from hospital treatments have helped in significant financial growth of hospitals. Homecare segment is forecast to grow at the fastest rate with the highest CAGR during the forecast period 2020-2025, owing to growing trends in personalized treatments, rising affordability and better care.

Asia-Pacific dominates the geography segment of Cholera Treatment Market with a share of more than 44.15% in 2019, followed by North America. Growing prevalence of cholera disease among a large section of the population, growing awareness about treatment of the diseases, increasing healthcare affordability of the majority population and government initiatives to vaccine launches and immunization have helped in the growth of Cholera Treatment Market infrastructure in this region. North America held the second place in the geography segment share of the market, owing to increasing health awareness among the masses and presence of key market players in the region.

North America is estimated to grow at the fastest rate at a higher CAGR during the forecast period 2020-2025. This is owing to presence of well-developed infrastructure, awareness among people about cholera treatment and vaccination and major product launches and other market developments by key players.

Researchers have estimated that each year there are 1.3 million to 4.0 million cases of cholera, and 21000 to 143000 deaths worldwide owing to cholera. Up to 80% of cases can be successfully treated with oral rehydration solution (ORS). Severe cases need rapid treatment with intravenous fluids and antibiotics. Provision of safe water and sanitation is critical to control the transmission of cholera and other waterborne diseases. A global strategy on cholera control with a target to reduce cholera deaths by 90% was launched in 2017. This has driven the market growth in recent years.

In recent years, government has taken up initiatives and campaigns in order to fight cholera pandemic. Some of the strategies include favorable policies on distribution of vaccines. In view of these factors, the market is poised to see significant growth during the forecast period 2020-2025.

In order to maintain the demand of the vaccines and treatment of cholera, health awareness is important. However, consumption of unclean water and polluted environment lead to rise in fatality rates owing to chronic diseases. As such, the people are unaware of cholera treatment. Thus, it is anticipated to hamper the market growth during the forecast period 2020-2025.

Product launches, mergers and acquisitions, joint ventures and R&D activities are key strategies adopted by players in the Cholera Treatment Market. In 2019, Cholera Treatment Market share is consolidated by the top players present in the market. Cholera Treatment Market top 10 companies are Valneva SE, Sanofi, Emergent BioSolutions Inc, EUBIOLOGICS CO., LTD,  Astellas Pharma Inc, Johnson & Johnson, Celldex Therapeutics, GlaxoSmithKline plc, Merck & Co., Inc and Sun Pharmaceutical Industries Ltd among others.